Preview: AcelRx Pharmaceuticals gains ahead of Q1 results

Talphera

13/05/2022 17:39

** Shares of specialty pharmaceuticals co  ACRX.O  up nearly
8% at 22 cents 
    ** ACRX set to report Q1 results on Monday
    ** Co is expected to report 7.6% increase in revenue to
$550,000 from $511,000 a year ago, according to Refinitiv data
    ** Co is expected to post narrower loss of 6 cents a share,
according to data from Refinitiv, compared to 8 cents per share
    ** ACRX down 66% so far this year
    

 (Reporting by Mehnaz Yasmin in Bengaluru)
 ((Mehnaz.Yasmin@thomsonreuters.com))